Twitter Delicious Facebook Digg Stumbleupon Favorites More

Showing posts with label Awards. Show all posts
Showing posts with label Awards. Show all posts

Tuesday, April 26

AVT biotech Awards & Certifications

  • APEDA award for the years 2006-2007, 2007 -2008, 2008-2009 for outstanding export performance. ( APEDA – Agricultural & Processed Food Products Exports Development Authority – Ministry of Commerce & Industry Government of India ).
  • Certificate of Recognition by the Accreditation unit of The Department of Biotechnology Ministry of Science & Technology Government of India.
  • Approved as an accredited source for the export of Tissue Cultured plants into Australia by the Australian Quarantine & Inspectionservices (AQUIS )
  • Government of Kerala Certified Nursery for the sale of Ornamental & Fruit Plants.

Biocon AWARDS




Kiran Mazumdar-Shaw has received several awards on behalf of Biocon and in her personal capacity as one of India's leading business entrepreneurs.
Biocon:

2010

Biocon wins Bio-Excellence Award for Outstanding Achievement in the Healthcare Sector at Bangalore Bio

2009

Biocon among Top 20 Indian companies in Forbes ‘Best Under A Billion’ list.

Biocon wins Bio-Excellence Award for Outstanding Achievement in the Healthcare Sector at Bangalore Bio

Syngene wins Bio-Excellence Award for outstanding achievement in the Biotech Service Sector at Bangalore Bio

Biocon bags IDMA "Best Patent of the year" award

BIOMAb EGFR®  was voted ‘Bio-Spectrum Asia-Pacific Product of the year’, 2008

Biocon wins prestigious BioSingapore Asia Pacific Biotechnology Award for Best Listed Company
2008

Biocon is ranked among the top 20 global biotechnology companies (Source: Med Ad News, June 2008)

Biocon is the 7th largest biotech employer in the world (Source: Med Ad News, June 2008)

2007

Syngene receives "BioServices Company of the Year", BioSpectrum Awards

Biocon's BIOMAb EGFR® wins "Product of the Year",
BioSpectrum Awards
2006

Best IT User Award in the Pharmaceutical Sector, NASSCOM
2004

India's first and No. 1 biotech company with a global ranking of 16* (Source: Biospectrum July 2004)

Biocon in India's top 5 Life Sciences companies (at close of trade as on July 30, 2004)

Best Reinvention of HR Function Award, Indira Group, Mumbai

Best Employer Of India Award, Hewitt

2003

Bio-Business Award for bio-entrepreneurship, Rabo India

Express Pharma Pulse Award for excellence in the
pharmaceutical industry

2001

Biotech Product, Process Development and Commercialisation Award, Department of Biotechnology, Ministry of Science and Technology, Government of India

2000

Technology Pioneer Recognition, World Economic Forum
1985

Export Performance Award, Karnataka State Financial
Corporation (KSFC)

National Award for Best Small Industry, Government of India

Kiran Mazumdar-Shaw:
2010

Featured on the Forbes list of ‘The World’s 100 Most Powerful Women’.

Featured on the Financial Times ‘Top 50 Women in Business’ list.

Named among TIME magazine’s 100 most influential people in
the world.
2009

Honoured with 'Nikkei Asia Prize' for Regional Growth

Honoured with 'Express Pharmaceutical Leadership Summit Award' for Dynamic Entrepreneur

2008

Honorary Degree of Doctor of Science from the Heriot-Watt University, Edinburgh

Honorary Degree of Doctor of Science from the University of Glasgow

2007

Honoured with the, 'Veuve Clicquot Initiative For Economic Development For Asia' award

Honorary Doctor of Technology, University of Abertay, Dundee ( UK )

2005

Padmabhushan Award , one of India's highest civilian honours, from the President of India, Dr. APJ Abdul Kalam

Honorary Degree of Doctor of Science (Honoris Causa) from Indian Institute of Technology, Roorkee
The Indian Chamber of Commerce Lifetime Achievement Award

Honorary Doctorate from Manipal Academy of Higher Education (MAHE), in recognition of outstanding achievements in biotechnology and industrial enzymes

Rotary Award for Corporate Citizenship

Business Leader of the Year Award - Biotechnology,
Chemtech-Pharma Bio Awards

2004

Honorary Doctorate of Science from Ballarat University, in recognition of pre-eminent contribution to the field of biotechnology

Business Woman Of The Year Award, The Economic Times
2003

Alumni High Achiever Award, Australian Alumni Association

2002

Karnataka Rajyotsava Award for pioneering biotechnology in India, the Government of Karnataka

Best Entrepreneur: Healthcare & Life Sciences Award,
Ernst & Young

Sir M. Visvesvaraya Memorial Award for contribution
to biotechnology, Federation of Karnataka Chambers
of Commerce & Industry (FKCCI)

1999

Woman of the Year Award, International Women's
Association, Chennai

1998

Golden Jubilee Felicitation, Mount Carmel College, Bangalore

1989

Padmashri for pioneering biotechnology in India,
Government of India
1987

Outstanding Young Person Award, Jaycees India
1983

Best Small Scale Industry in Karnataka Award, Rotary Club, Karnataka

Best Model Employer Award, Rotary Club, Karnataka

Outstanding Contribution Award, AWAKE

1982

Best Woman Entrepreneur Award, National Institute of
Marketing Management, India

Biotechnology Heritage Award

Joshua Boger Joshua Boger

2011 Winner: Joshua Boger

The Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) have selected Joshua Boger as the winner of the 2011 Biotechnology Heritage Award. The award will be presented during BIO’s annual international convention, to be held in Washington, D.C., June 27–30, 2011.
Boger is the founder of Vertex Pharmaceuticals Incorporated. He retired as Vertex’s CEO in 2009, but he continues to serve on the Vertex Board. Prior to founding Vertex in 1989, Boger was senior director of basic chemistry at Merck Sharp & Dohme Research Laboratories, where he headed the departments of Biophysical Chemistry and Medicinal Chemistry of Immunology and Inflammation. During his ten years at Merck, Boger developed an international reputation as a leader in the application of computer modeling to the chemistry of drug design and was a pioneer in the use of structure-based rational drug design as the basis for drug discovery programs.
Boger holds a bachelor's degree in chemistry and philosophy from Wesleyan University and both a master's and doctorate degrees in chemistry from Harvard University. His postdoctoral research in molecular recognition was performed in the laboratories of the Nobel Prize–winning chemist Jean-Marie Lehn. He is the author of more than 50 scientific publications, holds 32 issued U.S. patents in pharmaceutical discovery and development, and has lectured widely in the United States, in Europe, and in Asia on various aspects of drug discovery and development.  He was named one of forty Technology Pioneers worldwide for the 2003 World Economic Forum.
Boger is chair of the board of trustees of Wesleyan University, immediate-past-chairman of the Biopharmaceutical Industry Trade Association, a founding director and chairman of the New England Healthcare Institute, a founding director and  co-chairman of the Progressive Business Leaders Network, chair of the board of fellows of the Harvard Medical School, and chair of the board of Boston's Celebrity Series.

About the Biotechnology Heritage Award

The Biotechnology Heritage Award is presented yearly at a special ceremony during the BIO Annual International Convention to honor individuals who have contributed significantly to the growth of biotechnology through discovery, innovation, commercialization, and/or public understanding. In honoring these individuals, the Chemical Heritage Foundation and the Biotechnology Industry Organization seek to encourage emulation, inspire achievement, and promote public understanding of modern science, industry, and economics in this rapid-growth area.
The cosponsorship of the award complements the mission of both organizations by advancing their mutual goals of educating the public, nourishing a sense of pride and community within the industry, and developing the record of the remarkable contributions the molecular sciences make to our lives.

About the Biotechnology Industry Organization (BIO)

The Biotechnology Industry Organization (BIO) represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial, and environmental biotechnology products.

About the Chemical Heritage Foundation (CHF)

The Chemical Heritage Foundation (CHF) fosters an understanding of chemistry’s impact on society. An independent nonprofit organization, we strive to
  • Inspire a passion for chemistry;
  • Highlight chemistry’s role in meeting current social challenges; and
  • Preserve the story of chemistry and its technologies and industries across centuries.
CHF maintains major collections of instruments, fine art, photographs, papers, and books. We host conferences and lectures, support research, offer fellowships, and produce educational materials. Our museum and public programs explore subjects ranging from alchemy to nanotechnology.

NYU School of Medicine 2011 Dart/NYU Biotechnology Achievement Award Presented for Role of Pure Science

Three Biomedical Researchers Receive 2011 Dart/NYU Biotechnology Achievement Award

April 11, 2011

The Biotechnology Study Center of NYU School of Medicine will hold its 11th annual awards symposium on April 11, 2011, to honor three outstanding leaders in biomedical research. The Dart/NYU Biotechnology Achievement Awards recognize the role of pure science in the development of pharmaceuticals and honors those scientists whose work has led to major advances to improving care provided at the patient’s bedside. Recipients of this year’s award include:
Dart/NYU Biotechnology Achievement Award in Basic Biotechnology:
Shirley M. Tilghman, PhD, FRS, Professor of Biology and President, Princeton University, for demonstrating genomic imprinting is an epigenetic process.
Dart/NYU Biotechnology Achievement Award in Applied Biotechnology:
George M. Martin, MD, Professor of Pathology Emeritus (active), Director Emeritus, Alzheimer’s Disease Research Center, Adjunct Professor of Genome Sciences (retired), University of Washington; Visiting Scholar, Molecular Biology Institute, UCLA, for defining molecular targets in aging and Alzheimer’s disease.
Dart/NYU Biotechnology Achievement Faculty/Alumnus Award:
Paul S. Aisen, MD, Director, Alzheimer's Disease Cooperative Study, Professor, Department of Neurosciences, University of California at San Diego, for translating Alzheimer’s disease research into clinical trials.
"We applaud this year’s distinguished honorees for their innovative research. Epigenetics is a powerful new field of human biology and Dr. Tilghman has made perhaps its most significant discovery to date. Additionally, the research conducted by Dr. Martin and Dr. Aisen on the molecules of Alzheimer’s disease has profoundly influenced the diagnosis and treatment of this disease," said Gerald Weissmann, MD, research professor, Department of Medicine, Division of Rheumatology, director, Biotechnology Study Center. "The discoveries of these three remarkable scientists have already changed our approach to health and disease and they promise even more for the future."
The Biotechnology Study Center is an academic center for the study of biotechnology with the end-goal of significantly improving public health. The Dart/NYU Biotechnology Achievement Awards have been supported by a generous grant from Dart Neuroscience LLC since 2004 and are awarded on behalf of the Fellows of the Center at The Biotechnology Center.
BACKGROUND ON 2011 AWARD RECIPIENTS: Dart/NYU Biotechnology Achievement Award in Basic Biotechnology
Shirley M. Tilghman, PhD, FRS, Professor of Biology and President, Princeton University, has been a leader in the field of epigenetics, a field that studies the ways in which the expression of genes can be affected by modifications to the DNA that encode them. Before her appointment as President of Princeton University, Dr. Tilghman was Howard A. Prior Professor of the Life Sciences in the Department of Molecular Biology and Director of the Lewis Sigler Institute for Integrative Genomics at Princeton. A native of Winnipeg, Manitoba, she graduated from Queen's University in Kingston, Ontario in 1968. After two years of secondary school teaching in Sierra Leone, West Africa, she obtained her PhD in biochemistry from Temple University in Philadelphia, Pennsylvania. In the 1970's, when she was a post-doctoral fellow in Dr. Philip Leder's lab at the NIH, Dr. Tilghman helped isolate one of the first mammalian genes: the beta globin gene – which she found to be interrupted by non-coding sequences – a then novel and exciting finding. Her major contribution has been the analysis of imprinting: the ways genes are chemically modified, depending on whether they are inherited from the mother or the father. These modifications lead to the parent-specific silencing of genes. For example, Dr. Tilghman and her colleagues have studied how insulin-like growth factor 2 gene, the most critical fetal growth signal, is imprinted. The copy of the gene inherited from the father is active, while that inherited from the mother is silent. Dr. Tilghman has been recognized for this work by election to the American Philosophical Society, the National Academy of Sciences, the Institute of Medicine and the Royal Society of London. She also serves as a trustee of the Carnegie Endowment for International Peace and is a member of the Board of Directors at Google.

Dart/NYU Biotechnology Achievement Award in Applied Biotechnology
George M. Martin, MD, Professor of Pathology Emeritus (active), Director Emeritus, Alzheimer’s Disease Research Center, Adjunct Professor of Genome Sciences (retired), University of Washington; Visiting Scholar, Molecular Biology Institute, UCLA, has deciphered the genes that cause aging and memory loss. These findings have pinpointed where drugs should work to intervene in time and memory disorders.
Dr. Martin received his BS and MD degrees from the University of Washington and has served on its faculty since 1957. After house staff training at Montreal General Hospital and the University of Chicago, he became a postdoctoral fellow of Guido Pontecorvo at Glasgow University, and has had other postdoctoral positions with Francois Gros in Paris and Henry Harris and Richard Gardner at Oxford. Dr. Martin’s research has included the positional cloning of the Werner syndrome gene followed by the demonstrations of the genomic instability and accelerated replicative senescence of Werner somatic cells. He also conducted the first cell fusion studies of dominance/recessivity relationships between old cells, young cells and "immortal" cells. In recent years, Dr. Martin has carried out a linkage analysis of familial Alzheimer disease, due to mutations in presenilin (PS). This led to the mapping of PS1&2 and the cloning of PS2. His lab synthesized the first line of transgenic mice with a knock-in of a human mutation of PS1. A conditional knockout of PS1 revealed a correlation between diminished hippocampal stem cell replication and aberrations in memory. Each of these observations has generated targets for therapeutic intervention. Dr. Martin has received the highest awards of the Gerontological Society of America, the Irving Wright Award of the American Federation for Aging Research, and a World Alzheimer Congress Lifetime Achievement Award. He is a Senior Member of the Institute of Medicine of the National Academy of Sciences, the Scientific Director of the American Federation for Aging Research and the Chair of the Scientific Advisory Board of the Ellison Medical Foundation.
Dart/NYU Biotechnology Achievement Faculty/Alumnus Award
Paul S. Aisen, MD, Director, Alzheimer's Disease Cooperative Study, Professor, Department of Neurosciences, University of California at San Diego is the chief coordinator of United States clinical studies of Alzheimer’s disease by virtue of his translational research on inflammation in the brain. Dr. Aisen received his BA from Harvard and an MD from Columbia. After residency training at Mt. Sinai he served as a fellow in Rheumatology at NYU School of Medicine. He then returned to Mt. Sinai where he initiated groundbreaking studies on inflammation and its treatment in Alzheimer’s. His research has suggested mechanisms of inflammation in the brain that pointed to new therapeutic strategies in Alzheimer's disease. Dr. Aisen joined the faculty at Georgetown University in 1999 where he founded the Memory Disorders Program, a clinical and research program for Alzheimer's disease and related disorders. Since 2002 he has been in his present position, where recent publications reveal the basic and applied sides of his investigative reach, including Neurology and Journal of Pharmacology Experimental Therapeutics.


Media Inquiries:
Deborah (DJ) Sabalusky
212-404-3500 | deborah.sabalusky@nyumc.org

CALL FOR CONCEPT NOTES IN RNAi TECHNOLOGY


imageGovernment of India
Department of Biotechnology
Ministry of Science and Technology
Technology Bhavan, New Mehrauli Road
New Delhi -110016.
ADVT. NO. DST / 03 / 2010 – Rectt.
CALL FOR CONCEPT NOTES IN RNAi TECHNOLOGY
Small non-coding RNAs, including siRNA, miRNA and piRNAs play essential regulatory roles in a variety of phenomena including epigenetic regulation, genome control and stability, development, metabolic engineering, innate immunity and adaptive responses to biotic and abiotic stresses. These small RNAs are the backbones of RNAi activities and have revolutionized the biology of gene regulation. DBT invites the concept notes, intending to address various issues related to health, agriculture and environment using RNAi science/technology approaches. The applicants are encouraged to submit concepts in the areas related to:
 RNAi Biology
Ø  Identification of genome wide RNAi factors in various organisms to manipulate the RNAi potential
Ø  Identification of total cellular factors responsible for disease susceptibility or resistance using genome wide RNAi
Ø  Unraveling the underlying molecular process for various diseases /metabolic  /physiological processes in animal or plant model using RNAi approach
Ø  Profiling and prediction of miRNAs responsible for organism development and stress
Ø  pi RNA biogenesis and function
Development of tools for research, early translation/ product development
Ø  Search for miRNA biomarkers for known diseases
Ø  Developing genome wide shRNA libraries
Ø  Chemical synthesis of stable small RNAs and their target specific delivery
Translational research related to use of RNAi based approaches
Ø  Developing transgenics with economic traits using RNAi approach
The concept should run not in more than two pages* and must include (a) significance, (b) novelty, specific objectives and brief work plan (c) expected outcomes/deliverables, (d) tentative budget and, (e) biodata on one separate page* to highlight the expertise and experiences in the subject area/s. All segments i.e. Academia, NGOs etc. individually or in collaboration are encouraged to submit the concept note. The concept notes, duly signed by head of the institute, should be sent to Dr D K Tiwary, Principal Scientific Officer, Department of Biotechnology, Block-2, CGO Complex, Lodi Road, New Delhi- 110004. by 15th January 2011. The concept notes will be screened in the last week of January, 2011 for developing into full projects.
*the concept note will be ignored if it runs in more than three pages including the bio data

LTMT Mumbai Biological Science Young Researcher Award-2011

LADY TATA MEMORIAL TRUST
Founded 1932
Bombay House, Homi Mody Street
Mumbai 400 001 E-mail:    fjguard@sdtatatrust.com
Applications are invited for the “Young Researcher Award – 2011”
This Scheme is instituted by the Lady Tata Memorial Trust (LTMT) to recognise and reward young Indian scientists with an outstanding track record in biological sciences, a deep commitment to find innovative solutions to major problems related to human diseases and the potential for high quality research. Applicants should have publications in well recognised, peer reviewed journals of repute and contributed to knowledge generation that has created a significant impact in the field of translational possibilities. The applicant should also highlight prestigious award(s) and other recognitions such as Award(s) of major academies / societies.
Applications along with separate summary sheets (8 copies), duly forwarded by the host institute as per pro forma (attached), may be sent to:
The Secretary,
Lady Tata Memorial Trust,
Bombay House,
24 Homi Mody Street, Fort,
Mumbai 400 001.
OBJECTIVES:
The aim is to reward Young Researchers (< 40 years) who have displayed a potential for high quality research.
SCOPE:
All areas of Life Sciences and Biotechnology related to human diseases will be covered by this Award.
ELIGIBILITY:
i)    The Award is open to Indian Nationals, residing in India, who are below the age of 40 years as on 31st March 2011.
ii)    The applicant should possess a Ph.D. degree in any Biological Science or a Master’s degree in Medical Sciences, or an equivalent degree in Biotechnology related areas. The applicant must have at least 4 years of professional experience in the specific area after obtaining the above degree.
iii)   The candidate must have a regular position in a University / Organisation / Institute and should be engaged in research and development. Applicants currently working abroad may apply, provided that they have a confirmed placement in an Institute in India. Weightage will be given to applicants with publications arising from research done as an independent investigator in India. The awardee will be eligible for regular research grants through extramural and other research schemes of various S&T agencies of the Government of India.
ABOUT THE AWARD:
Ø  The amount of the Award will be Rs. 10,000/- per month in addition to a regular salary from the host institute.
Ø   In addition, the Young Researcher will receive a contingency grant of Rs. 5.00 lakhs per annum for meeting the expenses on consumables, minor equipment, international and domestic travel, manpower and other contingent expenditure to be incurred in connection with the implementation of the research project under the Award.
HOST INSTITUTION:
The Institution where the candidate is working will provide the necessary infrastructure and administrative support for pursuing research under this Award. Applicants currently working abroad may apply, provided they have a confirmed placement in an Institute in India.
DURATION:
The duration of the Award will be initially for three years, extendable further by two years, on a review by the Experts’ Committee.
PROCESSING FEE:
A Money Order of Rs. 500/- being the Processing Fee (non-refundable) should be forwarded in favour of the Lady Tata Memorial Trust, and the original postal receipt of the same should be attached at the top of the original set of the application form.

Please note:

The candidate must submit the application strictly in conformity with the pattern given in the Pro-Forma. THE APPLICATION SHOULD BE FRESHLY COMPUTER-GENERATED.  TYPED / HAND-WRITTEN APPLICATIONS  WILL BE  REJECTED.

The candidate must forward the application through the Director of a recognised Research Institute or Laboratory where he proposes to work. The application must be accompanied by:
EIGHT SETS (original application + seven copies) of the application must be submitted.  Please note that the application sets should only be corner-stapled and SHOULD NOT BE BOUND IN ANY OTHER  MANNER. The application should be addressed to The Secretary, Lady Tata Memorial Trust, Bombay House,  24 Homi Mody Street, Mumbai 400 001, so as to reach him not later than 14th January 2011.
Please super-subscribe on the left hand top corner of your postal cover YRA-2011 as the code for your Award.
The selected applicants will be called for an interview in the middle / third week of March 2011 and based on a personal interview; one young researcher will be announced by the end of March 2011. The selected researcher will be required to commence research effective, 1st April 2011.
Applicants must comply with the above instructions, strictly.  An application will not be considered if the candidate fails to furnish the requisite information and supporting documents, certificates and letters.  It may please be noted that testimonials, reprints and other papers received with the application will not be returned. Any canvassing, direct or indirect, will entail disqualification.
Advertisement on LTMT Mumbai Biological Science Young Researcher Award-2011

Indegene Life Systems Scientific Writing Manager Opening

Indegene Life Systems
Bangalore
Manager Scientific Writing
Experience 3 to 4 years
Position Type Full Time
Functional Area Scientific Content
Education Ph.D, MBBS, MD
Work Location Bangalore
Job Description:
1. Develop scientific medical content for all projects, meeting international quality standards
2. Deliver medical content that is rated high on depth, comprehensiveness, quality, and timelines
3. Interface with clients on a regular basis to meet their expectations
4. Control/reduce the cost of content development, cycle times, and error rates in projects
5. Develop innovative medical content products by leveraging on the depth of scientific content
Desired Profile
1. Minimum 1 to 3 years of experience in pharmaceutical companies in any of the following functions-medical services/medico-marketing/clinical research/regulatory affairs or in medical writing/developing/publishing medical content-or a minimum of 1 to 3 years of experience in any clinical practice
2. Understanding of any specialty area of medicine (preferred) or an overall understanding of the medical field
3. Strong flair and passion for writing
4. Strong written and verbal communication/presentation skills
5. Passion for networking
6. Being up-to-date with the latest technical/scientific developments and relating them to various projects
Soft Skills
• Client focus
• Result orientation
• Communicating with Impact
• Team player
• Process oriented

SOA Bhubaneswar PROGRAMME ON YOUNG GRADUATES FOR LEADERSHIP IN BIOTECHNOLOGY-2011

PROGRAMME ON YOUNG GRADUATES FOR LEADERSHIP IN BIOTECHNOLOGY-2011
11th – 12th February, 2011
image
Center of Biotechnology
Siksha O Anusandhan University
Bhubaneswar, Odisha
Centre of Biotechnology, is a constituent institute affiliated to Siksha O Anusandhan University, Bhubaneswar. It was established in the year 2007 to foster the need of biotechnology and life science research in eastern India. The Institute is actively engaged In advanced research in the realm of plant, animal, mineral, microbial and molecular biotechnology. The institute also imparts two years of M.Sc programme in Industrial Biotechnology, M.Tech in Biotechnology and Ph.D programme.
In order to encourage bright young science students who are studying in their final year of graduation to pursue higher studies and take up/built a career in scientific research, Centre of Biotechnology is going to organize a two days programme on 11th – 12th February, 2011 as part of the Biotechnology advancement programme of the University. The aim of the progremme Is to expose talented pre graduate science studenls to the excitement, fulfillment, challenge and rewards of pursuing a career in Biotechnology. They will be exposed to the R&D work and facilities at Centre of Biotechnology and also given inspiring lectures by eminent faculties during this programme.
Those students who have secured 60% or more In their intermediate/Class XII examination may apply for participation in this programme (attested mark sheet must be enclosed for verification). The institute will select students from various colleges, Institutes and Universities in order of merit. The selected students will be invited to visit the laboratory during 11th – 12th February, 2011 along with one of their Faculty member as nominated by the organization. Free hostel accommodation for outstation participants will be arranged.There will be a quiz test for the participants based on the Two days programme, on the basis of which three best participants will be awarded along with participation certificates.

NASI Allahabad YOUNG SCIENTIST PLATINUM JUBILEE AWARDS FOR THE YEAR 2011

The National Academy of Sciences, India (NASI)
Allahabad – 211002
NASI-YOUNG SCIENTIST PLATINUM JUBILEE AWARDS FOR THE YEAR 2011
NASI invites nominations for the above awards for the year 2011. The nominee should be an Indian citizen / Overseas citizen of India working in India and below the age of 35 years as on April 15, 2011. The award has been instituted by the NASI to recognize promise, creativity and excellence in young scientists. The award shall be made in recognition of notable contributions made by him/her in any branch of S&T recognized by the NASI on the basis of work carried out in India.
Number and Value of Awards
The number of awards to be made in any year will be limited to five. Each award carries a Citation, Bronze Medal and Rs. 25,000 in cash.
Nominators and Last Date
A candidate may be proposed by a Fellow of the National Academy of Sciences, India. Scientific Society of national standing, university faculty, Post-Graduate department or research institutions may also make nominations of eligible candidates.
A candidate may only be nominated once. However, a nomination will remain valid for consideration for 3 years or the age eligibility which ever expires earlier.
The nomination shall be made in the prescribed format. 20 copies of nomination form along with only one soft copy (in CD), complete in all respects along with 20 copies of reprints of five most important publications and all supporting documents, must reach the Academy latest by April 15, 2011.
Selection of the Awardees
As per Regulations of NASI.
Presentation of the Awards
The presentation of Awards will be made by the President, NASI, at the time of Annual General Body Meeting.
Details and Nomination form also available on NASI’s website http://www.nasi.org.in and http://www.nasi.nic.in
Advertisement on NASI Allahabad YOUNG SCIENTIST PLATINUM JUBILEE AWARDS FOR THE YEAR 2011

DBT Call for Proposals under Biotechnology Industry Partnership Programme (BIPP) (13th Batch) Opens on 15th Feb, 2011

Call for Proposals under BIPP (13th Batch)
Announcement Date (opens on): 15/02/2011
Last Submission Date: 31/03/2011
Department of Biotechnology (DBT) invites proposals from lndian Biotechnology Companies under the Biotechnology Industry Partnership Programme (BIPP), a Government partnership with industry for support on a cost sharing basis for development of novel and high risk futuristic technologies mainly for viability gap funding and enhancing existing R&D capacities. BIPP has been initiated under Biotechnology Industry Research Assistance Programme (BIRAP), a unique initiative of DBT being implemented in partnership with ABLE and BCIL to nurture R&D and innovation in Biotech Industry. Biotech Consortium lndia Limited (BCIL) is the BIPP Management Agency and will ensure maintenance of strict confidentiality of the proposals as per DBT norms.
Key Features of the Programme
  • Supports
    - Large, medium, small scale industry, start ups on cost sharing basis
    - High risk, discoverylinked innovation
    - Accelerated technology development
    - Evaluation and validation of biotech products
    - Indigenous discovery, innovation and technology to products
    - Products of national relevance or public benefit
  • Varying models of grants, loans or grant + loan available.
Who Can Apply?
A single or consortia of Indian “for profit” company (ies) – Small, Medium or Large having DSIR* recognized in-house R&D unit(s).  An Indian Company is defined as one which is registered under “The Indian Companies Act, 1956” and in which 51% (or more) of the ownership is held by Indian citizens (including NRIs).
The proposals can be submitted:
  • by an Indian Company alone; or
  • by an Indian Company along public sector R&D institution(s), organization(s), laboratory (ies), university (ies) etc.; or
  • by a consortium of Indian Companies; or
  • by a consortium of Indian Companies along with public sector R&D institution(s), organization(s), laboratory (ies), university (ies) etc.
(*Companies in the process of obtaining DSIR recognition may also apply along with the proof of application to DSIR. However, the final decision on such applications would be subject to their getting DSIR recognition)
Eligible Categories and Corresponding Relevant Areas
  • Category I&II : Agriculture, Bio- medical devices and instruments, Bio-energy, Bioinformatics, Environmental biotechnology,Health-care,Industrial products and processe
  • Category IIIA : Health Care Clinical trial
  • Category IIIB : Transgenic Field trial
  • Category IV : Agriculture, Bio- medical devices and instruments, Bio-energy, Bioinformatics, Environmental biotechnology, Health-care, Industrial products and processe
How to Apply?
Proposals are required to be submitted online only. To submit a proposal online, please follow the following steps:
  1. Log on the BIRAP website (www.birapdbt.nic.in)
  2. If you are a registered user, log-on using the credentials, else you need to register your company with by clicking on New User Registration.
  3. In case of new user registration, a computer generated password would be sent to the email-id provided at the time of registration. The password can be changed later.
  4. Once you login, you would be navigated to the page displaying BIPP link.
  5. Click on the BIPP link under Programmes and the active call would be highlighted.
  6. Click on the new call and proceed towards proposal submission.
Further details on How to submit a proposal would be available in the BIPP User Guide available on the website.
The proposals should be submitted on or before 31st March, 2011 (midnight).
Company User Registration is open round the clock.
Online Proposal Submission would begin from 15th February, 2011. No Hard Copy to be submitted, Proposals submitted online only would be considered.
Last date for Submission of Proposals: 31st March, 2011
For further details, please contact:
Dr. Renu Swarup,
Advisor Incharge-BIPP, Department of Biotechnology,
Block No: 2, 7th Floor, CGO Complex, Lodi Road, New Delhi – 110 003, India;
E-mail:
swarup@dbt.nic.in
**For Any queries related to  Online submission of proposals under BIPP, please write to bipp@dbt.nic.in
Detailed guidelines for the scheme including eligible project categories to be supported are available at
http://dbtindia.nic.in/uniquepage.asp?id_pk=680 ; http://www.birapdbt.nic.in/programmes.php

NASI RELIANCE INDUSTRIES PLATINUM JUBILEE AWARDS 2011 in Biological Sciences

The National Academy of Sciences, India (NASI)
Allahabad 211 002
NASI–Reliance Industries Platinum Jubilee Awards for the Year 2011 for Application Oriented Innovations Covering Both Physical and Biological Sciences
NASI invites nominations for the above awards for Application Oriented Innovations for the year 2011. The nominee should be an Indian citizen/Overseas citizen of India working in India and below the age of 50 years as on 15 April 2011.
Areas for the Awards:
Physical Sciences including – Chemistry, Engineering, Mathematics, Physics, Electronics, Nanotechnology, Information and Computer Sciences, Earth and Atmospheric Sciences;
Biological Sciences including – Agriculture, Animal and Plant Sciences, Environment, Biotechnology, Biochemistry, Bioprocess Engineering, Bioinformatics, all branches of Medical Sciences and Nanotechnology.
Number and value of awards: Two in Physical Sciences and two in Biological Sciences each year. Each award
carries a Plaque and Rs 2 lakhs in cash.
Nominators and last date: All Science Secretaries, Secretary HRD, Director Generals – CSIR, ICMR and ICAR; Directors of IITs, IIITs, National Laboratories, Industries with well recognized R&D units including private research institutions; Vice-Chancellors of all Universities – Central and State; Directors of Indian Institute of Science, Bangalore, AIIMS, New Delhi, PGI’s of Medical Research, Chairman, UGC; Presidents of all Science and Engineering Academies (Engineering, Medical, Agriculture); All Fellows of the NASI.
The nomination shall be made in the prescribed format. Twenty copies of nomination form along with only one soft copy (in CD), complete in all respect with the supporting documents, must reach the Academy latest by 15 April 2011. A candidate may only be nominated once. However, a nomination will remain valid for consideration for 3 years or the age eligibility which ever expires earlier.
Selection of the Awardees: As per Regulations of NASI.
Presentation of the Awards: The presentation of the Awards will be made at the time of 81st Annual Session of NASI.
Details and Nomination form also available on NASI’s website http://www.nasi.org.in and http://www.nasi.nic.in

L’OREAL-UNESCO Awards For Women in Science 2011

LOREAL-UNESCO Awards
lOREAL Corporate Foundation
Jennifer CAMPBELL
41,rue Martre -. 92117 Clichy cedex – France
Call for Nominations 2012  Nomination
We are pleased to launch the call for nominations for the 2012 L’OREAL-UNESCO Awards For Women in Science dedicated to the Life Sciences.
Dear Professor,
You are invited to submit ca ndidates for the 2012 LOREAL-UNESCO Awards in Li fe Sciences. You can propose outstanding women scientists from any continent.
The five US$ 100,000 Awards will be presen ted in March 2012 at UNESCO Headquarters in Paris to five women sc ientists who have made an outstanding contribution to scientific advancement.
You will find enclosed a ca ll for nominations describing the procedures, the official nomination form (one per geographic reg ionl. and a brochure of the Award Laureates from 1998 through 2010.
THE DEADLINE FOR SUBMITTING NOMINATIONS IS APRIL 29th 2011
The lOREAL-UNESCO Awards Jury in Life Sciences is presided by Professor Gunter Blobel, Nobel Prize in Medicine 1999, in the presence of Professor Christian de Duve, Nobel Prize in Medicine 1974 and Founding President of the Awardso In 2010, the Jury designated the following Laureates in Life Sciences:
Professor Rashika EL RIDI (Egypt) for AFRICA & the ARAB STATES
Professor Lourdes Jo CRUZ (Philippines) for ASIA- PACIFIC
Professor Anne DEJEAN-ASSEMAT (France) for EUROPE
Professor Alejandra BRAVO (Mexico) for LATIN AMERICA
Professor Elaine FUCHS (USA) for NORTH AMERICA.
Since Its inception in 1998, the For Women in Science partnership expands each year. To date, the LOREAL-UNESCO Awards have distinguished 62 eminent women scientists at the height of their career and the International Fellowships have supported 150 promising young women scientists to pursue doctoral and postdoctoral research projects. In addition, a network of National and Regional Fellowship programs at the doctoral level, now in over 56 countries with new programs launching each year, has encouraged over 800 young women to continue their sCientific research studies within their country of origin. An historic moment for the Awards arrived when two of the 2009 Nobel Prizes in sCience were awarded to Laureates of the 2008 L’OREAL-UNESCO Awards in Life Sciences:
Elizabeth Blackburn IUSA) in Medicine and Ada Yonath Iisraell in Chemistry. We thank you for your active participation in ensuring that the best women in research from each continent are recognized and rewarded for their scientific excellence.
Background
The lOREAL-UNESCO Awards are attributed each year to distinguish eminent women scientists at the height of their career. The 2012 Awards will be given to 5 women scientists who have made a significant contribution in the Life Sciences. One Award is given per geographic region as follows:
- Africa / Arab States
- Asia (including Oceania and Pacificl
- Europe
- Latin America
- North America (Canada and USA]
Each Award is worth US$ 100,000.
Selection Criteria
The candidate must:
• be recognized for her personal scientific excellence
• be actively involved in scientific research
• be involved in any field of the Life Sciences
Renominations:
If you wish to renominate a candidate you presented in the past, simply provide a completed nomination form and any new publications.
Required documents in English, to be attached to the Nomination Form: (no additional documents will be acceptedl
1- Nomination Form, completed and signed by the nominator [please submit only one nomination per form)
2- Curriculum vitae of the candidate [2 pages maximum)
3- Copies of her 5 most important publications
4- A complete list of the candidate’s main publications, in order of importance [please do not include the full publications)
5- Nomination Summary form
6- A maximum of 2 letters of recommendation from people at other institutions
Optional Documentation:
A more elaborate description of the candidate’s achievements [no more than 2 pages)

NISCAIR Delhi Biochemistry/Biotech/Life Sciences Research Interns Reruitments

NATIONAL INSTITUTE OF SCIENCE COMMUNICATION ANDINFORMATION RESOURCES,
Dr. K. S. Krishnan Marg, Near Pusa Gate New Delhi – 110012
WALK-IN-INTERVIEW for RESEARCH INTERN AWARDS
NISCAIR will conduct Walk-in-interview/Test on 19th and 20th April, 2011 for selection of Research Interns under “CSIR Diamond Jubilee Research Intern Awards” Scheme in the area of Library and Information Science, Botany, Zoology, Chemistry, Physics, Biochemistry/Biotechnology/Microbiology, Science Communication, Life Sciences, Languages (German/Chinese/Japanese/French/Korean/Arabic) and Earth Science/Oceanography/Geology as per details given in the detailed advertisement available at NISCAIR’s website. The number of Research Interns is 21 tentatively and may increase or decrease depending upon the requirement.
The detailed Advertisement, subject wise dates for interview / test and prescribed application form can be downloaded from NISCAIR website – http://www.niscair.res.in.
Eligible candidates fulfilling the criteria and having interest in above fields may appear for the Walk – in- interview / Test along with application form on the specified dates. Candidates must report at the NISCAIR reception desk between 9.00 AM to 10.30 A.M.